Effectiveness of Umonium38 against Burkholderia pseudomallei, Escherichia coli, Pseudomonas aeruginosa and Methicillin-Resistant Staphylococcus aureus (MRSA)
In: BMC Infectious Diseases, Jg. 24 (2024), Heft 1, S. 1-6
Online
academicJournal
Zugriff:
Abstract Aims We investigated the antibacterial efficacy of Umonium38 and Virkon® against Burkholderia pseudomallei, Escherichia coli, Pseudomonas aeruginosa and Methicillin-Resistant Staphylococcus aureus (MRSA) up to 14 days following treatment. Methods and results Umonium38 was diluted to 0.5%, 1.0%, 1.5%, 2.0%, 2.5% and 3%, tested against the bacterial strains at various contact times (15 min to 24 h), and incubated for up to 14 days. A minimum concentration of 0.5% Umonium38 with a contact time of 15 min effectively killed approximately 108 CFU/ml of all four bacterial species. No growth was observed on agar plates from day 0 until day 14 for all six concentrations. The bacteria were also inactivated by a 30-minute treatment time using Virkon® 1% solution. Conclusions Umonium38 effectively inactivates B. pseudomallei, E. coli, P. aeruginosa and MRSA at a concentration of ≥ 0.5% with a contact time of at least 15 min. The antimicrobial effect of Umonium38 remained for 14 days.
Titel: |
Effectiveness of Umonium38 against Burkholderia pseudomallei, Escherichia coli, Pseudomonas aeruginosa and Methicillin-Resistant Staphylococcus aureus (MRSA)
|
---|---|
Autor/in / Beteiligte Person: | Ruanchaiman, Soiratchaneekorn ; Amornchai, Premjit ; Wuthiekanun, Vanaporn ; Langla, Sayan ; Maroongruang, Peerapol ; Khanh Kim Le ; Blacksell, Stuart D. |
Link: | |
Zeitschrift: | BMC Infectious Diseases, Jg. 24 (2024), Heft 1, S. 1-6 |
Veröffentlichung: | BMC, 2024 |
Medientyp: | academicJournal |
ISSN: | 1471-2334 (print) |
DOI: | 10.1186/s12879-024-09102-9 |
Schlagwort: |
|
Sonstiges: |
|